Bristol Myers Squibb Gets New Nvidia AI Power
Bristol Myers Squibb is the first medical company to buy an Nvidia DGX SuperPOD using the new Vera Rubin architecture. This high speed computer system is designed to handle complex data at a massive scale.
The company will use this hardware to improve their drug discovery process. By processing data faster, researchers hope to identify promising treatments much earlier than before.
Nvidia recently launched this architecture to help companies solve difficult scientific problems. This partnership shows how big drug makers are investing heavily in new technology to change how they build medicine.
Comments (0)
No comments yet. Be the first!
More AI news
NewsNew AI Tool Fixes Mistakes in Financial Research
Researchers developed a new framework to stop AI from learning from its own bad data in financial trading models.
NewsPerplexity adds local AI to Mac apps
The new update lets your Mac handle some AI tasks directly on your computer.
NewsMeta Releases Muse Image Model on Fal
Meta has launched a new AI model on the Fal platform that plans and edits images on its own.